Actively Recruiting

All Genders
ID04487340

Computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2022-11-23

200000

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

S

Second Affiliated Hospital, School of Medicine, Zhejiang University

Lead Sponsor

S

Shaoxing People's Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The burden of stroke has increased significantly in China over the past 30 years, making it the leading cause of death. Researchers aim to improve data collection and medical quality management by creating an online database for acute stroke patients. This prospective multi-center study focuses on patients with acute ischemic stroke who receive reperfusion therapy and are hospitalized for stroke treatment. Data from these patients are collected through an emergency platform and a stroke medical quality control platform. The information recorded includes demographics, risk factors such as hypertension, diabetes, and atrial fibrillation, prior antiplatelet use, timing from stroke onset to hospital arrival, baseline stroke severity scores, infarct volume, and laboratory results. The study also provides education to participating centers to help clinicians improve medical quality. Participants' clinical outcomes are assessed at 3 months and 1 year, focusing on independence measured by the modified Rankin Scale (mRS). Additional outcomes include mortality, brain hemorrhage occurrence shortly after hospitalization, and the incidence of recurrent stroke or other vascular events at 1 and 5 years. The study is observational and involves no experimental treatment, lasting several years to track long-term outcomes.

CONDITIONS

Brief Title

Computer-based Online Database of Acute Stroke Patients for Stroke Management Quality Evaluation

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Acute stroke patients
Not Eligible

You will not qualify if you...

  • No

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to 5 years

Participants who undergo routine care are observed and data related to their stroke treatment and recovery are collected.

Assessments at hospitalization, 3 months, 1 year, and 5 years

Trial Site Locations

Total: 1 location

1

Min Lou

Hangzhou, Zhejiang, China, 310000

Actively Recruiting

Loading map...

Research Team

M

Min Lou, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Simple Imaging Versus Standard Imaging Selection in Stroke P...

Stroke, Ischemic

Actively Recruiting

8 locations

Prehospital Initiation of Reperfusion Therapy for Acute Isch...

Stroke, Acute

Actively Recruiting

11 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Comparing Outcomes of Thrombectomy Versus Intravenous Thrombolysis Based on Middle Cerebral Artery M2 Occlusion Features.

Huan Zhou, Wansi Zhong, Tingxia Zhang...

https://pubmed.ncbi.nlm.nih.gov/38787930